|
ImClone Systems Incorporated - SWOT AnalysisPublished by: Datamonitor Published: May. 20, 2008 - 28 Pages Table of Contents
AbstractDatamonitor's ImClone Systems Incorporated - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.ImClone Systems (ImClone) is a biopharmaceutical company specializing in the development of therapeutic products for the treatment of cancer and cancer-related disorders, as well as diagnostic products and vaccines for a number of infectious diseases. ImClone is headquartered in New York City, New York and employs about 1,000 people. The company recorded revenues of $590.8 million during the fiscal year ended December 2007, a decrease of 12.8% over 2006. The operating profit of the company was $51.5 million during fiscal year 2007, compared to an operating profit of $289.2 million in 2006. The net profit in fiscal year 2007 was $39.8 million, compared to a net profit of $370.7 million in 2006. Scope of the Report
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||